Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

The TRADE

FEBRUARY 29, 2024

The London Stock Exchange (LSEG) saw overall growth across its key businesses in 2023, with considerable improvement across data and analytics, capital markets, and in particular, post-trade. year-on-year increase, while capital markets saw a 6.1% rise year-on-year as compared to 2022. In capital markets, the 6.1%

Trading 113

Trading Acquisitions Capital Market Book-building 113

The TRADE

AUGUST 14, 2023

Redburn Atlantic will build upon the combined firms’ corporate access programmes, which previously provided more than 400 corporate and expert events and brought 40% of the S&P 500 by market cap to Europe last year.

Broker 52

Broker Equities Mergers IPO 52

Cooley M&A

FEBRUARY 7, 2023

That said, cross-border M&A remained largely resilient in 2022, with a return to healthy pre-pandemic levels, and while the types of deals we see in 2023 may evolve, many observers believe that deal volume will remain buoyant throughout the year. Regulators, particularly in the US, are becoming more skeptical of remedies in merger cases.

M&A 59

M&A Mergers and Acquisitions Mergers Finance 59

Mergers and Inquisitions

NOVEMBER 22, 2023

The name “bulge bracket” (BB) comes from the prospectus for an IPO or debt issuance, which lists all the banks underwriting the deal. As another example, some argue that UBS should not be a bulge bracket bank because it has focused on wealth management and areas outside the capital markets.

Bulge Bracket 105

Bulge Bracket Bank Banking Boutique 105

Cooley M&A

JANUARY 25, 2023

Tech M&A in 2022 was a tale of two halves. billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 billion [1] during the first half of 2022 to $189.17 billion in the second half, resulting in total 2022 volume of $720.3 trillion. [2] trillion.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. on transactions dominating the life sciences landscape into 2022. [4].

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40